drug · antibody drug conjugate
ozuriftamab vedotin
Phase 2updated 3mo agoby $BCAB BioAtla, Inc.🔗 ChEMBL
Phase 2community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Phase 2 (across all indications), with 2 investigational indications.
indications
indications
NSCLCColorectal Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying ozuriftamab vedotin
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that